REDS-IV-P Joins RESPONSE to Support Surveillance of SARS-CoV-2


The National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study IV–Pediatric (REDS-IV-P) Data Coordinating Center (DCC) administered by Westat will support new research to further our understanding of viruses and their pathogenesis, particularly amidst the SARS-CoV-2 pandemic. This project, REDS Epidemiology, Surveillance, and Preparedness of the Novel SARS-CoV-2 Epidemic, is known as RESPONSE. The project is funded by the National Institute of Allergy and Infectious Diseases in collaboration with NHLBI of the National Institutes of Health (NIH). This is a 1-year project valued at $1.5 million.

The RESPONSE study will

  • Evaluate SARS-CoV-2 assays that could potentially be used to screen for the presence of the virus
  • Conduct serosurveys to study how many people have been exposed to the SARS-CoV-2 virus in outbreak regions and developed antibodies against it
  • Enroll COVID-19 positive subjects in a longitudinal cohort study to answer fundamental questions on the evolution of viremia and early immune response
  • Establish a sharable biorepository for future research

As part of the research team, Westat, as the REDS-IV-P DCC, will use its research data collection platform made up of a suite of tools to support enrollment, consent, online surveys, data entry forms, biospecimen management, scheduling, monitoring, reporting, and analysis. These tools allow for flexibility, responsiveness, and capacity with respect to the study protocols, and ensures high-quality data. Westat’s secure FISMA-compliant data center, operating 24/7, will host the platform.

Westat will provide quality control for all data and harmonize study data received from the research sites and the REDS-IV-P Center for Transfusion Laboratory Studies (Vitalant Research Institute, San Francisco, CA), as well as other potential collaborators or data sources. We will develop submission protocols, standardized data formats, and systems for routinely and securely transferring data to the DCC. Once received, the data will be tracked, cleaned, processed, and made available for reporting and analysis.

“This important study will answer key questions about how many people have evidence of having contracted SARS-CoV-2 and advance our understanding of the natural history and pathogenesis of this new virus,” said Sunitha Mathew, the REDS-IV-P project director and a Westat Associate Director for Public Health and Epidemiology.

Want to work with us?
You’ll be in great company.

About Us Careers

Westat Employees.
Westat Employee.
AAA Foundation for Traffic Safety
Baltimore Metropolitan Council
Centers for Disease Control and Prevention
Centers for Medicare & Medicaid Services
Chicago Metropolitan Agency for Planning
DC Public Schools
Georgia Department of Transportation
Internal Revenue Service
Leadership Montgomery
Maryland Cancer Registry
Michigan Department of Health and Human Services
National Science Foundation
NYC Mayor’s Office for Economic Opportunity
Organization for Economic Cooperation and Development
Robert Wood Johnson Foundation
Social Security Administration
Substance Abuse and Mental Health Services Administration
Teach for America
Texas Education Agency
The Johns Hopkins University
The National Institutes of Health
The Verizon Foundation
U.S. Department of Agriculture
U.S. Department of Education
U.S. Department of Health and Human Services
U.S. Department of Justice
U.S. Department of Transportation
U.S. Department of Veterans Affairs
University of Maryland Baltimore Campus
University of Michigan
University System of Maryland
Explore Our Clients

Please wait...

Forbes 2023 America's Best Mid-Size Employers Powered by Statista Forbes 2022 The Best Employers for Women Powered by Statista

Westat is an Equal Opportunity Employer and does not discriminate on the basis of race, creed, color, religion, sex, national origin, age, veteran status, disability, marital status, sexual orientation, citizenship status, genetic information, gender identity or expression, or any other protected status under applicable law. Notices to Employees & Applicants.